Product Name | MF | CAS | Details |
---|
PF 00356231 | C25H20N2O3S | 766536-21-4 | Details |
PHA-767491 | C12H11N3O | 845714-00-3 | Details |
R 406 | C22H23FN6O5 | 841290-80-0 | Details |
PF 3845 | C24H23F3N4O2 | 1196109-52-0 | Details |
PH 797804, (±)- - rac-PH 797804 | rac-PH 797804 | C22H19BrF2N2O3 | 586379-66-0 | Details |
PF 477736 - PF 00477736 | C22H25N7O2 | 952021-60-2 | Details |
PLX 4032 - RG 7204 | Vemurafenib | RO 5185426 | C23H18ClF2N3O3S | 918504-65-1 | Details |
PF 03814735 | C23H25F3N6O2 | 942487-16-3 | Details |
PI 103 hydrochloride | C19H17ClN4O3 | 371935-79-4 | Details |
RS-1 - RAD51-Stimulatory Compound-1 | C20H16Br2N2O3S | 312756-74-4 | Details |
PF 06463922 - Lorlatinib | C21H19FN6O2 | 1454846-35-5 | Details |
Rapamycin - Sirolimus | C51H79NO13 | 53123-88-9 | Details |
PF 4693627 - PF 04693627 | C26H29Cl2N3O3 | 1312815-93-2 | Details |
SB 747651A - SB 747651 tetrahydrochloride | Details |
Pyroxamide | C13H19N3O3 | 382180-17-8 | Details |
RG 108 | C19H14N2O4 | 48208-26-0 | Details |
PF 02341066 - Crizotinib | PF 2341066 | C21H22Cl2FN5O | 877399-52-5 | Details |
PIK 90 | C18H17N5O3 | 677338-12-4 | Details |
RO 4929097 | C22H20F5N3O3 | 847925-91-1 | Details |
PF 04981517 - CYP3cide | PF 4981517 | C26H32N8 | 1390637-82-7 | Details |
PF 543 citrate | C33H39NO11S | 1415562-83-2 | Details |
PDK1 inhibitor 2610 | 2108463-93-8 | Details |
REP 3123 dihydrochloride - CRS3123 dihydrochloride | C19H20Br2ClN3O2S | 1013915-99-5 | Details |
Rbin-1 - Ribozinoindole-1 | C13H12N4S | 328023-11-6 | Details |
SB 203580 | C21H16FN3OS | 152121-47-6 | Details |
Perifosine - KRX 0401 | D 21266 | C25H52NO4P | 157716-52-4 | Details |
RO 28-0450 - RO 28-1675, (±)- | C18H22N2O3S2 | 300352-96-9 | Details |
PF 4708671 - PF 04708671 | C19H21F3N6 | 1255517-76-0 | Details |
PF 04691502 | C22H27N5O4 | 1013101-36-4 | Details |
Rolipram, (R)-(-)- | C16H21NO3 | 85416-75-7 | Details |
Rolipram | C16H21NO3 | 61413-54-5 | Details |
Regorafenib - BAY 73-4506 | Stivarga | C21H15ClF4N4O3 | 755037-03-7 | Details |
PKI 587 - PF 05212384 | C32H41N9O4 | 1197160-78-3 | Details |
SB 939 - Pracinostat | C20H30N4O2 | 929016-96-6 | Details |
PF 4800567 | C17H18ClN5O2 | 1188296-52-7 | Details |
PHA 408 | C29H27ClFN7O2 | 503555-55-3 | Details |
PNU 100480 - PF 02341272 | U 100480 | Sutezolid | C16H20FN3O3S | 168828-58-8 | Details |
RI-1 | C14H11Cl3N2O3 | 415713-60-9 | Details |
PND 1186 - SR 2516 | VS 4718 | C25H26F3N5O3 | 1061353-68-1 | Details |
PS 47 | C17H15ClO2 | 1180676-33-8 | Details |
PRT 4165 - NSC 600157 | C15H9NO2 | 31083-55-3 | Details |
PF 956980 | C18H26N6O | 1262832-74-5 | Details |
PTIQ | C13H17NO3 | 1032822-42-6 | Details |
SB 706504 - PCG | C24H19F3N8O | 911110-38-8 | Details |
RIPA-56 | C13H19NO2 | 1956370-21-0 | Details |
Rbin-2 - Ribozinoindole-2 | C13H11BrN4S | 2032282-97-4 | Details |
Pravadoline - WIN 48098 | C23H26N2O3 | 92623-83-1 | Details |
R 547 | C18H21F2N5O4S | 741713-40-6 | Details |
PF 573228 | C22H20F3N5O3S | 869288-64-2 | Details |
PF 431396 | C22H21F3N6O3S | 717906-29-1 | Details |
SB 590885 | C27H27N5O2 | 405554-55-4 | Details |
RO 28-1675 - RO 28-0450, (R)- | C18H22N2O3S2 | 300353-13-3 | Details |
PIK 75 hydrochloride | C16H14BrN5O4S | 945619-31-8 | Details |
PF 04859989 hydrochloride - L-3-Amino-3,4-dihydro-1-hydroxycarbstyril hydrochloride | C9H11ClN2O2 | 177943-33-8 | Details |
RKI 1447 | C16H14N4O2S | 1342278-01-6 | Details |
SAR405838 - MI-77301 | C29H34Cl2FN3O3 | 1303607-60-4 | Details |
SAR405 | C19H21ClF3N5O2 | 1523406-39-4 | Details |
PFK 158 | C18H11F3N2O | 1462249-75-7 | Details |
S3QEL 2 | C19H25N5 | 890888-12-7 | Details |
SB 207499 - Cilomilast | Ariflo | C20H25NO4 | 153259-65-5 | Details |
SB 203580 hydrochloride | C21H17ClFN3OS | 869185-85-3 | Details |
PF 06447475 | C17H15N5O | 1527473-33-1 | Details |
RBC 8 | C25H20N4O3 | 361185-42-4 | Details |
Rolipram, (S)-(+)- | C16H21NO3 | 85416-73-5 | Details |
Reversine | C21H27N7O | 656820-32-5 | Details |
SB 202190 | C20H14FN3O | 152121-30-7 | Details |
RO 61-8048 | C17H15N3O6S2 | 199666-03-0 | Details |
PHT 427 | C20H31N3O2S2 | 1191951-57-1 | Details |
Rigosertib sodium - ON01910 sodium | Estybon | C21H24NNaO8S | 592542-60-4 | Details |
RGFP 966 | C21H19FN4O | 1357389-11-7 | Details |
PF 06465469 | C30H33N7O2 | 1407966-77-1 | Details |
RO 28-1674 - RO 28-0450, (S)- | C18H22N2O3S2 | 599164-57-5 | Details |
PU-H71 trihydrochloride | 2108826-10-2 | Details |
RAF709 | C28H29F3N4O4 | 1628838-42-5 | Details |
RUSKI-201 dihydrochloride | Details |
PFM01 | C14H15NO2S2 | 1558598-41-6 | Details |
Piperlongumine - Piplartine | C17H19NO5 | 20069-09-4 | Details |
PLX 4720 | C17H14ClF2N3O3S | 918505-84-7 | Details |
PS 48 | C17H15ClO2 | 1180676-32-7 | Details |
Santacruzamate A - CAY 10683 | C15H22N2O3 | 1477949-42-0 | Details |
PF 06260933 dihydrochloride | C16H14Cl2N4 | 1883548-86-4 | Details |
PRMT3 inhibitor 1 - Compound 1 | C15H18N4OS | 1340875-03-7 | Details |
Roflumilast - Daxas | BY 217 | BYK 20869 | B 9302-107 | C17H14Cl2F2N2O3 | 162401-32-3 | Details |
RITA - NSC 652287 | C14H12O3S2 | 213261-59-7 | Details |
REP 8839 | C20H21BrFN3OS | 757942-43-1 | Details |
Ruxolitinib - INCB 018424 phosphate | C17H21N6O4P | 1092939-17-7 | Details |
PF 05081090 - PF 5081090 | C18H21FN2O6S | 1312473-63-4 | Details |
PF 04447943 - PF 4447943 | C20H25N7O2 | 1082744-20-4 | Details |
PluriSIn #1 - NSC 14613 | Pluripotent cell-specific inhibitor #1 | C12H11N3O | 91396-88-2 | Details |
RU-SKI 43 hydrochloride | C??H??ClN?O?S | Details |
RAD51 inhibitor B02 | C22H17N3O | 1290541-46-6 | Details |
PKG drug G1 | C13H11N3OS | 374703-78-3 | Details |
Salermide | C26H22N2O2 | 1105698-15-4 | Details |
RO 3306 | C18H13N3OS2 | 872573-93-8 | Details |
Remodelin | C15H14N4S | 949912-58-7 | Details |
PPP hydrochloride | C14H22ClN | 21602-56-2 | Details |
PXS 4728A - PXS 4728 HCl | C15H22ClFN2O2 | 1478364-68-9 | Details |
SB 216763 | C19H12Cl2N2O2 | 280744-09-4 | Details |
PS 1145 | C17H11ClN4O | 431898-65-6 | Details |
Posaconazole - SCH 56592 | Noxafil | C37H42F2N8O4 | 171228-49-2 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 7 8 |